0
A new study in Science Advances adds weight to a growing body of evidence that iron dysregulation may play an important role in Alzheimer’s disease and therefore might provide a better target for treatments than amyloid beta plaques.
A new study in Science Advances adds weight to a growing body of evidence that iron dysregulation may play an important role in Alzheimer’s disease and therefore might provide a better target for treatments than amyloid beta plaques.